首页 | 本学科首页   官方微博 | 高级检索  
检索        

一平苏对维持性血透患者心血管保护作用的临床观察
引用本文:刘沁,叶朝阳,方平,高文武.一平苏对维持性血透患者心血管保护作用的临床观察[J].中华高血压杂志,2001,9(2):114-116.
作者姓名:刘沁  叶朝阳  方平  高文武
作者单位:1. 第二军医大学长征医院, 肾内科
2. 第二军医大学长征医院, B超室
摘    要:观察一平苏对维持血透患者的心血管保护作用。方法30例有高血压和左室肥厚并维持血透的患者随机分为两组,A组20例用一平苏2.5mg~5mg/d,B组给予不会影响左室重构的其它药作为对照。6个月后心脏多普勒超声检查左室重构及功能的情况。结果两组虽均有明显降压,但一平苏组治疗后LVDd,IVS,LVPWD和LVMI均有统计学意义的下降,EF和E/A均明显升高。结论一平苏不仅可安全有效地降压,还可逆转血透患者的左室肥厚及使左室舒张功能改善。

关 键 词:血透    高血压    西拉普利    左室肥厚    左室功能
文章编号:1006-2866(2001)02-0114-02
修稿时间:2000年5月20日

Cardiovascular Protection Effect of Cilazapril in Hypertensive Hemodialysis Patients
LIU Qin,YE ChaoYang,FANG Ping,GAO Wenwu.Cardiovascular Protection Effect of Cilazapril in Hypertensive Hemodialysis Patients[J].Chinese Journal of Hypertension,2001,9(2):114-116.
Authors:LIU Qin  YE ChaoYang  FANG Ping  GAO Wenwu
Abstract:Objective:To investigate the cardiovascular protection effect of cilazapril in hemodialystic patients|(HD). Methods:Thirty HD with hypertension and left ventricular hypertrophy patients were randomly divided into two groups.Group A(n=20) cilazapril 2.5 mg~5 mg,group B(n=10) as control. After six mouths,the left ventricular mass and function were monitored by color Doppler cardiography. Results:BP was decreased in both group.LVDd,IVS,LVPWD and LVMI were decreased in cilazapril group. Conclusion:Cilazapril is not only effective and safe in treatment of hypertension,reversed the ventricular hypertrophy and improved the diastolic function in HD patients also.
Keywords:hemodialysis  cilazapril  hypertension  Left ventricular hypertrophy and function
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号